Nottingham Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,355
| Closed | -$212K | – | 144 |
|
|
2022
Q1 | $212K | Hold |
2,355
| – | – | 0.03% | 133 |
|
|
2021
Q4 | $264K | Hold |
2,355
| – | – | 0.03% | 123 |
|
|
2021
Q3 | $296K | Hold |
2,355
| – | – | 0.03% | 115 |
|
|
2021
Q2 | $319K | Sell |
2,355
-600
| -20% | -$81.3K | 0.04% | 112 |
|
|
2021
Q1 | $401K | Sell |
2,955
-290
| -9% | -$39.4K | 0.05% | 106 |
|
|
2020
Q4 | $457K | Buy |
3,245
+455
| +16% | +$64.1K | 0.07% | 92 |
|
|
2020
Q3 | $311K | Buy |
+2,790
| New | +$311K | 0.04% | 106 |
|